Terapêutica Substitutiva com Imunoglobulina G Polivalente: Particularidades de um Coorte Português
-
Published:2024-03-04
Issue:
Volume:
Page:
-
ISSN:1646-0758
-
Container-title:Acta Médica Portuguesa
-
language:
-
Short-container-title:Acta Med Port
Author:
Cosme Ferreira SofiaORCID, Vieira JosefinaORCID, T. Silva Maria InêsORCID, P. Silva SaraORCID, Caiado JoanaORCID, Pedro ElisaORCID, L. Silva SusanaORCID
Publisher
Ordem dos Medicos
Reference10 articles.
1. Krivan G, Jolles S, Granados EL, Paolantonacci P, Ouaja R, Cissé OA, et al. New insights in the use of immunoglobulins for the management of immune deficiency (PID) patients. Am J Clin Exp Immunol. 2017;6:76-83. 2. Cherin P, Marie I, Michallet M, Pelus E, Dantal J, Crave JC, et al. Management of adverse events in the treatment of patients with immunoglobulin therapy: a review of evidence. Autoimmun Rev. 2016;15:71-81. 3. Jolles S, Orange JS, Gardulf A, Stein MR, Shapiro R, Borte M, et al. Current treatment options with immunoglobulin G for the individualization of care in patients with primary immunodeficiency disease. Clin Exp Immunol. 2015;179:146-60. 4. Chapel HM, Spickett GP, Ericson D, Engl W, Eibl MM, Bjorkander J. The comparison of the efficacy and safety of intravenous versus subcutaneous immunoglobulin replacement therapy. J Clin Immunol. 2000;20:94-100. 5. Lucas M, Lee M, Lortan J, Lopez-Granados E, Misbah S, Chapel H. Infection outcomes in patients with common variable immunodeficiency disorders: relationship to immunoglobulin therapy over 22 years. J Allergy Clin Immunol. 2010;125:1354-60.e4.
|
|